Retinal and optic nerve atrophy induced by intravitreous vincristine in the primate.
Vincristine is known to be toxic to neural tissue, where it is thought to react with microtubules and impair axonal transport. Intravitreous vincristing-induced changes of the retina have been reported to be reversible after 10 micrograms. In the present study, the effects of 0.01 to 100 micrograms of intravitreous vincristine in monkeys were studied ophthalmoscopically and by light microscopy and electron microscopy. Retinal degeneration and optic atrophy were evident ophthalmoscopically in two to three weeks. Morphological changes included swelling of retinal neurons, loss of organelles and microtubules and accumulation of fibrillar-granular material. Progression of effects, with plasma membrane rupture and cell death, was observed with all doses of 0.1 micrograms and higher. The retina and optic nerve of monkeys appear to be more sensitive to intravitreous vincristine than are the same structures in certain lower animals.
D000818:Animals; D005260:Female; D000882:Haplorhini; D007267:Injections; D008253:Macaca mulatta; D008268:Macular Degeneration / Q000139:chemically induced / Q000473:pathology; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced*; D009900:Optic Nerve / Q000473:pathology / Q000648:ultrastructure; D010786:Photoreceptor Cells / Q000648:ultrastructure; D010857:Pigment Epithelium of Eye / Q000648:ultrastructure; D012160:Retina / Q000473:pathology; D012163:Retinal Detachment / Q000139:chemically induced / Q000473:pathology; D012164:Retinal Diseases / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*; D014822:Vitreous Body
D014750:Vincristine